论文部分内容阅读
目的探讨雷尼替丁治疗80例急性胰腺炎的疗效。方法对2010年1月至2011年4月收治的80例急性胰腺炎患者随机分成两组,对照组给予氟尿嘧啶,实验组给予雷尼替丁治疗,对比两组疗效。结果对照组的总有效缓解时间短于实验组,差异具有统计学意义(P<0.05);对照组的总有效率低于实验组,差异有统计学意义(P<0.05);对照组血清淀粉酶值恢复正常的时间与实验组比较,差异无统计学意义(P>0.05)。结论雷尼替丁为强效H2受体拮抗剂,用于急性胰腺炎的治疗,疗效佳,值得临床推广。
Objective To investigate the efficacy of ranitidine in the treatment of 80 cases of acute pancreatitis. Methods Eighty patients with acute pancreatitis admitted from January 2010 to April 2011 were randomly divided into two groups. The control group was given fluorouracil, and the experimental group was treated with ranitidine. The curative effect was compared between the two groups. Results The total effective remission time of the control group was shorter than that of the experimental group (P <0.05). The total effective rate of the control group was lower than that of the experimental group (P <0.05) Enzyme values returned to normal time compared with the experimental group, the difference was not statistically significant (P> 0.05). Conclusions Ranitidine is a potent H2 receptor antagonist for the treatment of acute pancreatitis with good curative effect and worthy of clinical promotion.